Epidemiology of MPN: What Do We Know?
- L. A. AndersonAffiliated withCentre for Public Health, Queen’s University Belfast
- , M. F. McMullinAffiliated withCentre for Cancer Research and Cell Biology, Queen’s University Belfast Email author
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The myeloproliferative neoplasms, are characterised by overproduction of myeloid cells. Chronic myeloid leukaemia, polycythaemia vera, essential thrombocythaemia, myelofibrosis and the very rare disorders chronic neutrophilic leukaemia, chronic eosinophilic leukaemia not otherwise specified and mastocytosis are all included in the group. Incidence and prevalence rates reported in the worldwide literature are presented in this review. Survival data on each condition is described. Information on the aetiology of the disorders is discussed including body mass index, diet, smoking and alcohol, allergies, associated medical conditions, occupation and environmental exposures with focus on recent new studies. The aetiology of the myeloproliferative neoplasms remains unknown, and this review of the current state of knowledge highlights the need for further comprehensive research.
KeywordsEpidemiology Myeloproliferative neoplasms Survival Body mass index Diet Benzene
- Epidemiology of MPN: What Do We Know?
Current Hematologic Malignancy Reports
Volume 9, Issue 4 , pp 340-349
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Myeloproliferative neoplasms
- Body mass index
- Industry Sectors
- Author Affiliations
- 1. Centre for Public Health, Queen’s University Belfast, Grosvenor Road, Belfast, BT12 6BJ, Northern Ireland
- 2. Centre for Cancer Research and Cell Biology, Queen’s University Belfast, 97 Lisburn Road, Belfast, BT9 7AE, Northern Ireland